医療用チューブ市場規模、シェア、動向、2031年までの世界予測

医療用チューブ市場は、予測期間中に年平均成長率（CAGR）7.9%で推移し、2026年の134億米ドルから2031年には196億4,000万米ドルに達するとMarketsandMarketsでは予測しています。

医療用チューブ市場は、医療ニーズの増大や、安全かつ信頼性の高い高品質な流体・気体移送ソリューションへの需要を背景に、世界的に急速な成長を遂げています。この市場拡大の主な要因としては、慢性疾患の有病率の上昇、医療インフラの整備・進展、そして低侵襲手術法の普及などが挙げられます。さらに、患者の安全や医療機器の有効性に関する厳しい規制も、病院による次世代医療用チューブシステムの導入を後押ししています。加えて、製薬・バイオテクノロジー分野における活動の活発化や、シングルユース（単回使用​​）および使い捨て医療機器への需要拡大も、市場全体の成長に大きく寄与しています。

調査対象範囲

本調査レポートでは、医療用チューブ市場を、素材（プラスチック、ゴム、特殊ポリマー）、構造（シングルルーメン、マルチルーメン、共押出、テーパー／バンプ、ブレード補強）、および用途（バルク使い捨てチューブ、カテーテル・カニューレ、薬物送達システム、その他）に基づいて分類しています。また、市場の成長に影響を与える促進要因、抑制要因、課題、機会に関する詳細な情報も網羅しています。主要企業については、事業概要、製品ラインナップ、および合併・買収（M&A）、新製品投入、事業拡大といった主要戦略に関する詳細な分析を行い、市場における動向を把握するための知見を提供します。さらに、本レポートでは、医療用チューブ市場のエコシステムに参入する新興企業（スタートアップ）に関する競合分析も行っています。

本レポートを購入するメリット

本レポートは、市場のリーダー企業や新規参入企業に対し、医療用チューブ市場全体および各セグメントの収益規模に関する極めて精度の高い推定値を提供します。ステークホルダーは、本レポートを通じて競争環境を把握し、自社の事業の最適なポジショニングや、適切な市場参入戦略（Go-to-Market戦略）の策定に向けた深い洞察を得ることができます。また、市場の動向を理解し、主要な促進要因、抑制要因、課題、機会に関する情報を入手することが可能です。

本レポートでは、以下の点に関する知見を提供します。

主要な推進要因（高齢者人口の増加、低侵襲医療処置への需要拡大、押出成形技術の進歩、厳格な品質基準・規制）、阻害要因（材料適合性の制限、環境および廃棄に関する懸念）、機会（生体適合性材料やスマート材料の進歩、医療インフラの刷新・整備に向けた政府支出の増加）、および課題（高い生産コスト、マーケティングの複雑さ）の分析。

• 製品開発・イノベーション：医療用チューブ市場における次世代技術、研究開発活動、製品・サービスの投入に関する詳細な知見。
• 市場開拓：収益性の高い市場に関する包括的な情報（地域別の医療用チューブ市場分析を含む）。
• 市場の多角化：医療用チューブ市場における新製品・サービス、未開拓地域、最近の動向、投資活動に関する詳細情報。
• 競合分析：主要企業（Saint-Gobain [フランス]、Freudenberg Medical [米国]、W. L. Gore & Associates, Inc. [米国]、The Lubrizol Corporation [米国]、Nordson Corporation [米国]、TE Con​​nectivity [スイス]、Elkem ASA [ノルウェー]、Trelleborg AB [スウェーデン]、RAUMEDIC AG [ドイツ]、Teknor Apex [米国]など）の市場シェア、成長戦略、提供サービスに関する詳細な評価。

Report Description

The medical tubing market is expected to reach USD 19.64 billion by 2031 from USD 13.40 billion in 2026, at a CAGR of 7.9% during the forecast period.

The medical tubing market is experiencing rapid global growth, driven by rising healthcare demands and the need for safe, reliable, and high-quality fluid and gas transfer solutions. Key factors contributing to this market expansion include the rising prevalence of chronic diseases, advances in healthcare infrastructure, and the increasing use of minimally invasive surgical techniques. Additionally, stringent regulations regarding patient safety and device effectiveness are pushing hospitals to adopt next-generation medical tubing systems. The heightened activity in the pharmaceutical and biotechnology sectors, along with the rising demand for single-use and disposable medical devices, is also a significant contributor to the overall growth of the market.

“Plastics are projected to be the second-largest material segment in the medical tubing market during the forecast period.”

In the medical tubing market, plastics are expected to become the second-largest material segment. This is mainly due to their high performance, which arises from an excellent combination of flexibility, chemical resistance, and biocompatibility. Polyvinyl chloride (PVC) and polyethylene (PE) are two plastic materials that provide high mechanical strength and minimal moisture absorption, making them easy to process and suitable for a wide range of medical applications.

Plastic tubing is used in various settings, including IV infusion systems, blood transfusion lines, fluid delivery systems, and disposable medical products. It also plays a crucial role in drug development within the medical industry. Moreover, the large-scale production of plastic tubing, its resistance to sterilization methods, and its suitability for single-use medical items contribute to its growing demand in healthcare.

“Single-lumen tubing is projected to be the second-largest structure segment in the medical tubing market during the forecast period.”

In the medical tubing market, single-lumen tubing is expected to become the second-largest segment due to its simple design, affordability, reliability, and versatility across various healthcare applications. Single-lumen tubing facilitates rapid, uniform fluid delivery, making it a common choice for IV infusion systems, drainage systems, respiratory devices, and basic catheterization procedures. Its straightforward design allows for easy production through multiple methods, and the materials used are widely accessible. This tubing is often used in high volumes for disposable medical devices, which is a key factor contributing to its popularity across various medical applications. Additionally, the growing trend toward purchasing more affordable single-use medical devices and fluid management solutions is likely to boost the demand for single-lumen tubing in the coming years.

“Catheters & cannulas are projected to be the largest application segment in the medical tubing market during the forecast period.”

The catheters & cannulas segment is expected to be the largest application in the medical tubing market during the 2026–2031 forecast period. This is due to their use in both routine and critical medical procedures. Medical tubing in these applications provides a safe and reliable means of delivering or removing drugs, fluids, or gases within the human body.

Several factors are driving the growth of this segment, including the increase in chronic diseases, a rising number of surgical procedures, and a growing trend toward minimally invasive surgeries. Additionally, advancements in catheter and cannula design and materials, increased adoption of single-use medical tubing products, and rising demand for biocompatible materials are contributing to this segment’s growth.

” North America is projected to be the second-largest regional segment in the medical tubing market during the forecast period.”

North America is projected to be the second-largest market for medical tubing during the 2026–2031 forecast period. This growth is primarily due to the region’s well-developed healthcare infrastructure and the widespread adoption of innovative medical technologies. Additionally, North America has a robust manufacturing industry for medical devices, increasing healthcare spending, and a rising demand for minimally invasive procedures.

Key factors driving market growth include the rising number of individuals affected by chronic illnesses, the expansion of home healthcare services, and a strong regulatory focus on patient safety and product quality. Moreover, the presence of leading medical device companies in both the United States and Canada, along with ongoing investments in research and development and advanced polymer technologies, further enhances North America’s dominance in the global medical tubing market.

• By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
• By Designation: Directors (30%), Managers (20%), and Others (50%)
• By Region: North America (20%), Europe (10%), Asia Pacific (40%), South America (10%), and the Middle East & Africa (20%)

Note 1: Others include sales, marketing, and product managers.

Note 2: Tier 1: >USD 1 Billion; Tier 2: USD 500 million–1 Billion; and Tier 3: <USD 500 million

Companies Covered: Saint-Gobain (France), Freudenberg Medical (US), W. L. Gore & Associates, Inc. (US), The Lubrizol Corporation (US), Nordson Corporation (US), TE Connectivity (Switzerland), Elkem ASA (Norway), Trelleborg AB (Sweden), RAUMEDIC AG (Germany), and Teknor Apex (US).

The study includes an in-depth competitive analysis of these key players in the medical tubing market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the medical tubing market based on material (plastics, rubbers, specialty polymers), structure (single-lumen tubing, multi-lumen tubing, co-extruded tubing, tapered or bump tubing, braided tubing), and application (bulk disposable tubing, catheters & cannulas, drug delivery systems, other applications). The report’s scope covers detailed information regarding drivers, restraints, challenges, and opportunities influencing the growth of the medical tubing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products offered, and key strategies, such as mergers, acquisitions, product launches, and expansions, associated with the medical tubing market. This report covers a competitive analysis of upcoming startups in the medical tubing market ecosystem.

Reasons to Buy the Report

The report will provide market leaders/new entrants with the closest approximations of revenue numbers for the overall medical tubing market and its subsegments. This report will help stakeholders understand the competitive landscape, gain deeper insights into how to better position their businesses, and plan suitable go-to-market strategies. The report will help stakeholders understand the market pulse and provide information on key drivers, restraints, challenges, and opportunities.

The report provides insights into the following points:

Analysis of key drivers (growing geriatric population, increasing demand for minimally invasive medical procedures, advancements in extrusion technology, and stringent quality standards and regulations), restraints (limited material compatibility and environmental and disposal concerns), opportunities (advancements in biocompatible and smart materials and increasing governmental expenditure for upgrading and developing healthcare infrastructure), and challenges (high production costs and marketing complexities).

• Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the medical tubing market.
• Market Development: Comprehensive information about profitable markets; the report analyzes the medical tubing market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical tubing market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Saint-Gobain (France), Freudenberg Medical (US), W. L. Gore & Associates, Inc. (US), The Lubrizol Corporation (US), Nordson Corporation (US), TE Connectivity (Switzerland), Elkem ASA (Norway), Trelleborg AB (Sweden), RAUMEDIC AG (Germany), and Teknor Apex (US), among others.

Table of Contents

1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.3 STUDY SCOPE 26
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 26
1.3.2 INCLUSIONS AND EXCLUSIONS 26
1.3.3 YEARS CONSIDERED 27
1.3.4 CURRENCY CONSIDERED 27
1.3.5 UNITS CONSIDERED 27
1.4 STAKEHOLDERS 27
1.5 SUMMARY OF CHANGES 28
2 EXECUTIVE SUMMARY 29
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 29
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 30
2.3 DISRUPTIVE TRENDS SHAPING MEDICAL TUBING MARKET 31
2.4 HIGH-GROWTH SEGMENTS 32
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 33
3 PREMIUM INSIGHTS 34
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL TUBING MARKET 34
3.2 MEDICAL TUBING MARKET, BY MATERIAL 34
3.3 MEDICAL TUBING MARKET, BY STRUCTURE 35
3.4 MEDICAL TUBING MARKET, BY APPLICATION 35
3.5 MEDICAL TUBING MARKET, BY REGION 36
4 MARKET OVERVIEW 37
4.1 INTRODUCTION 37
4.2 MARKET DYNAMICS 37
4.2.1 DRIVERS 38
4.2.1.1 Growing aging population and chronic diseases 38
4.2.1.2 Increasing healthcare infrastructure investments 38
4.2.1.3 Increasing demand for minimally invasive medical procedures 39
4.2.1.4 Advancements in extrusion technology 39
4.2.1.5 Stringent quality standards and regulations 40
4.2.2 RESTRAINTS 41
4.2.2.1 Limited material compatibility 41
4.2.2.2 Environmental and disposal concerns 41

4.2.3 OPPORTUNITIES 42
4.2.3.1 Advancements in biocompatible and smart materials 42
4.2.3.2 Expansion of medical tourism and high-end healthcare facilities 43
4.2.4 CHALLENGES 43
4.2.4.1 High production costs and marketing complexities 43
4.3 UNMET NEEDS AND WHITE SPACES 44
4.3.1 UNMET NEEDS IN MEDICAL TUBING MARKET 44
4.3.2 WHITE SPACE OPPORTUNITIES 44
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 45
4.4.1 INTERCONNECTED MARKETS 45
4.4.2 CROSS-SECTOR OPPORTUNITIES 45
4.5 EMERGING BUSINESS MODELS AND ECOSYSTEM SHIFTS 45
4.5.1 EMERGING BUSINESS MODELS 45
4.5.2 ECOSYSTEM SHIFTS 46
4.6 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 47
4.6.1 KEY MOVES AND STRATEGIC FOCUS 47
4.7 PORTER’S FIVE FORCES ANALYSIS 48
4.7.1 THREAT OF NEW ENTRANTS 49
4.7.2 THREAT OF SUBSTITUTES 49
4.7.3 BARGAINING POWER OF SUPPLIERS 49
4.7.4 BARGAINING POWER OF BUYERS 50
4.7.5 INTENSITY OF COMPETITIVE RIVALRY 50
5 INDUSTRY TRENDS 51
5.1 INTRODUCTION 51
5.2 VALUE CHAIN ANALYSIS 51
5.3 REGULATORY LANDSCAPE 52
5.3.1 REGULATIONS 52
5.3.1.1 North America 52
5.3.1.2 Asia Pacific 53
5.3.1.3 Europe 53
5.3.2 STANDARDS 53
5.3.2.1 ISO standard 53
5.3.2.2 Food and Drug Administration (FDA) 54
5.3.2.3 ASTM (American Society for Testing and Materials) standards 54
5.3.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 54
5.4 TRADE ANALYSIS 57
5.4.1 IMPORT SCENARIO (HS CODE 3917) 57
5.4.2 EXPORT SCENARIO (HS CODE 3917) 57
5.5 ECOSYSTEM ANALYSIS 58
5.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 59
5.7 CASE STUDY ANALYSIS 60
5.7.1 FREUDENBERG MEDICAL TO PROVIDE SPECIALTY BALLOON CATHETERS 60
5.7.2 W. L. GORE & ASSOCIATES, INC. PROVIDES GORE STA-PURE PUMP TUBING 61
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 62
6.1 TECHNOLOGY ANALYSIS 62
6.1.1 KEY TECHNOLOGIES 62
6.1.1.1 Extrusion technology 62
6.1.1.2 Advanced material technologies 62
6.1.2 COMPLEMENTARY TECHNOLOGIES 63
6.1.2.1 Smart technologies and connectivity 63
6.1.2.2 Surface treatment and modification 63
6.2 KEY CONFERENCES AND EVENTS, 2026–2027 64
6.3 PATENT ANALYSIS 65
6.3.1 METHODOLOGY 65
6.3.2 DOCUMENT TYPES 65
6.3.3 PUBLICATION TRENDS IN LAST 10 YEARS 66
6.3.4 INSIGHTS 66
6.3.5 LEGAL STATUS OF PATENTS 66
6.3.6 JURISDICTION ANALYSIS 67
6.3.7 TOP APPLICANTS 68
6.4 FUTURE APPLICATIONS 69
6.4.1 ADVANCED, MINIMALLY INVASIVE, AND ROBOTIC SURGERY 69
6.4.2 CARDIOVASCULAR AND NEUROVASCULAR INTERVENTIONS 69
6.4.3 CELL AND GENE THERAPY 69
6.4.4 SUSTAINABLE MEDICAL TUBING 69
6.5 IMPACT OF AI/GEN AI ON MEDICAL TUBING MARKET 69
6.6 PRICING ANALYSIS 70
6.6.1 AVERAGE SELLING PRICE, BY REGION, 2022–2025 70
6.6.2 AVERAGE SELLING PRICE FOR TOP THREE APPLICATIONS, BY KEY PLAYER, 2025 71
6.6.3 AVERAGE SELLING PRICE TREND, BY MATERIAL, 2022–2025 71
6.7 INVESTMENT AND FUNDING SCENARIO 71
6.8 ADOPTION BARRIERS & INTERNAL CHALLENGES 72
6.9 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES 72
6.10 MARKET PROFITABILITY 73
6.10.1 REVENUE POTENTIAL 73
6.10.2 COST DYNAMICS 74
6.10.3 MARGIN OPPORTUNITIES IN KEY END-USE SECTORS 74

7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 75
7.1 INTRODUCTION 75
7.2 DECISION-MAKING PROCESS 75
7.3 KEY STAKEHOLDERS AND BUYING CRITERIA 76
7.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 76
7.3.2 BUYING CRITERIA 77
7.4 MACROECONOMIC INDICATORS 78
7.4.1 HEALTHCARE EXPENDITURES 78
7.5 IMPACT OF 2025 US TARIFF – OVERVIEW 79
7.5.1 INTRODUCTION 79
7.5.2 KEY TARIFF RATES 79
7.5.3 PRICE IMPACT ANALYSIS 79
7.5.4 IMPACT ON COUNTRY/REGION 80
7.5.4.1 US 80
7.5.4.2 Europe 80
7.5.4.3 Asia Pacific 81
7.5.5 IMPACT ON END-USE INDUSTRIES 81
8 MEDICAL TUBING MARKET, BY APPLICATION 82
8.1 INTRODUCTION 83
8.2 BULK DISPOSABLE TUBING 84
8.2.1 DEMAND FROM HOSPITALS, HOME HEALTHCARE PROVIDERS, AND EMERGENCY CARE PROVIDERS TO BOOST MARKET 84
8.2.2 DIALYSIS TUBING 85
8.2.2.1 Growing aging population to drive demand 85
8.2.3 INTRAVENOUS TUBING 85
8.2.3.1 Technological advancements to drive market 85
8.3 CATHETERS & CANNULAS 86
8.3.1 RISING CARDIOVASCULAR DISEASES AND DEMAND FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO DRIVE MARKET 86
8.3.2 CATHETERS 86
8.3.2.1 Increase in chronic diseases contributing to significant demand 86
8.3.2.2 Cardiovascular catheters 86
8.3.2.2.1 Growing elderly population and high incidence of cardiovascular diseases to drive market 86
8.3.2.3 IV catheters 87
8.3.2.3.1 Demand for direct delivery of medication and nutrients into bloodstream to fuel growth 87
8.3.2.4 Urinary catheters 87
8.3.2.4.1 Rising incidences of urinary tract infections and growing need for advanced technologies to drive demand 87

8.3.3 CANNULAS 87
8.3.3.1 Evolving healthcare sector and stringent regulatory requirements to support market growth 87
8.4 DRUG DELIVERY SYSTEMS 88
8.4.1 PRECISE DRUG DELIVERY TO TARGET SITES TO DRIVE DEMAND 88
8.4.2 NASOGASTRIC 88
8.4.2.1 Need for enteral feeding and drainage to fuel demand 88
8.4.3 NEBULIZERS 89
8.4.3.1 Conversion of liquid medications to mists for inhalation to drive market 89
8.5 OTHER APPLICATIONS 89
8.5.1 PERISTALTIC PUMP TUBING 89
8.5.1.1 Wide demand for minimizing contamination to boost market 89
8.5.2 GAS SUPPLY TUBING 89
8.5.2.1 Increasing minimally invasive surgeries to support market growth 89
8.5.3 SMOKE EVACUATION TUBING 90
8.5.3.1 Popularity of cosmetic procedures and medical tourism to drive market 90
9 MEDICAL TUBING MARKET, BY MATERIAL 91
9.1 INTRODUCTION 92
9.2 PLASTICS 93
9.2.1 BIOCOMPATIBILITY, CHEMICAL STABILITY, AND COST-EFFECTIVENESS TO BOOST MARKET 93
9.2.2 POLYVINYL CHLORIDE (PVC) 93
9.2.3 POLYOLEFIN 94
9.2.3.1 Polyethylene (PE) 94
9.2.3.2 Polypropylene (PP) 94
9.2.4 POLYAMIDE 95
9.2.5 POLYTETRAFLUOROETHYLENE (PTFE) 95
9.2.6 POLYETHER ETHER KETONE (PEEK) 95
9.2.7 POLYCARBONATE (PC) 96
9.3 RUBBERS 96
9.3.1 SIGNIFICANT DURABILITY AND RESILIENCE TO DRIVE DEMAND 96
9.3.2 THERMOPLASTIC ELASTOMER (TPE) 96
9.3.3 THERMOPLASTIC POLYURETHANE (TPU) 96
9.3.4 SILICONE 97
9.3.5 POLYURETHANE (PU) 97
9.3.6 ETHYLENE PROPYLENE DIENE MONOMER (EPDM) 97
9.3.7 LATEX 97
9.4 SPECIALTY POLYMERS 98
9.4.1 BIOABSORBABLE POLYMERS 98
9.4.2 ETHYLENE VINYL ACETATE (EVA) 98
9.5 OTHER MATERIALS 98
10 MEDICAL TUBING MARKET, BY STRUCTURE 99
10.1 INTRODUCTION 100
10.2 SINGLE-LUMEN 101
10.2.1 DEMAND FOR ADMINISTRATION OF FLUIDS AND MEDICATION, AIRWAY MANAGEMENT, AND PATIENT NUTRITION TO DRIVE MARKET 101
10.3 CO-EXTRUDED 102
10.3.1 DURABILITY, LUBRICITY, OPACITY, RADIOPACITY, AND TENSILE STRENGTH TO BOOST MARKET 102
10.4 MULTI-LUMEN 102
10.4.1 NON-TOXICITY, BIOCOMPATIBILITY, AND INERTNESS TO FUEL MARKET DEMAND 102
10.5 TAPERED OR BUMP TUBING 103
10.5.1 ENHANCED FUNCTIONALITIES IN CVC, PICC, AND DRUG DELIVERY CATHETERS TO DRIVE MARKET 103
10.6 BRAIDED TUBING 103
10.6.1 GOOD STRENGTH, STEERABILITY, AND PRESSURE RESISTANCE TO DRIVE MARKET 103
11 MEDICAL TUBING MARKET, BY REGION 105
11.1 INTRODUCTION 106
11.2 NORTH AMERICA 107
11.2.1 US 110
11.2.1.1 High disposable income and strong healthcare infrastructure to drive market 110
11.2.2 CANADA 112
11.2.2.1 Aging population and increasing healthcare expenditure to support market growth 112
11.2.3 MEXICO 114
11.2.3.1 High investments and low manufacturing costs to fuel demand 114
11.3 EUROPE 115
11.3.1 GERMANY 118
11.3.1.1 Advanced medical facilities and R&D investments to drive market 118
11.3.2 FRANCE 120
11.3.2.1 Rising elderly population to fuel market growth 120
11.3.3 UK 121
11.3.3.1 Innovation, technological advancements, and investments to drive market 121
11.3.4 SPAIN 123
11.3.4.1 Growing aging population and improvements in healthcare system to increase consumption 123
11.3.5 ITALY 124
11.3.5.1 Growing geriatric population and strong focus on research and innovation to drive market 124
11.3.6 NETHERLANDS 126
11.3.6.1 Rising home care treatment to increase demand 126
11.3.7 REST OF EUROPE 127
11.4 ASIA PACIFIC 129
11.4.1 CHINA 132
11.4.1.1 Investments in manufacturing medical devices to support market 132
11.4.2 JAPAN 134
11.4.2.1 Japan’s aging population increases demand for medical tubing 134
11.4.3 INDIA 135
11.4.3.1 Government initiatives, high purchasing power, and rising manufacturing output to fuel demand 135
11.4.4 SOUTH KOREA 137
11.4.4.1 Medical tourism to lead to market growth 137
11.4.5 REST OF ASIA PACIFIC 138
11.5 MIDDLE EAST & AFRICA 140
11.5.1 GCC COUNTRIES 143
11.5.1.1 Saudi Arabia 143
11.5.1.1.1 Government initiatives to support market growth 143
11.5.1.2 UAE 145
11.5.1.2.1 Government funding and rapidly developing private health sector to drive market 145
11.5.1.3 Rest of GCC 146
11.5.1.3.1 Government funding and rapidly developing private health sector to drive market 146
11.5.2 SOUTH AFRICA 147
11.5.2.1 Growing healthcare sector to drive market 147
11.5.3 EGYPT 149
11.5.3.1 Technological advancements and improving healthcare sector to fuel demand 149
11.5.4 REST OF MIDDLE EAST & AFRICA 150
11.6 SOUTH AMERICA 151
11.6.1 BRAZIL 153
11.6.1.1 Demographic shifts coupled with increasing investments in healthcare sector to drive market 153
11.6.2 ARGENTINA 155
11.6.2.1 Growing aging population to drive market 155
11.6.3 REST OF SOUTH AMERICA 156
12 COMPETITIVE LANDSCAPE 158
12.1 OVERVIEW 158
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2026 158
12.3 REVENUE ANALYSIS, 2025 161
12.4 MARKET SHARE ANALYSIS, 2025 161
12.5 COMPANY VALUATION AND FINANCIAL METRICS 164
12.6 BRAND COMPARISON 166
12.6.1 BIO-SIL TUBING 166
12.6.2 HELIXFLEX 167
12.6.3 ISOPLAST ETPU MEDICAL TUBING 167
12.6.4 GORE STA-PURE PUMP TUBING SERIES PFL 167
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 167
12.7.1 STARS 167
12.7.2 EMERGING LEADERS 167
12.7.3 PERVASIVE PLAYERS 168
12.7.4 PARTICIPANTS 168
12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 169
12.7.5.1 Company footprint 169
12.7.5.2 Region footprint 170
12.7.5.3 Structure footprint 171
12.7.5.4 Material footprint 172
12.7.5.5 Application footprint 173
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 174
12.8.1 PROGRESSIVE COMPANIES 174
12.8.2 RESPONSIVE COMPANIES 174
12.8.3 DYNAMIC COMPANIES 174
12.8.4 STARTING BLOCKS 174
12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 175
12.8.5.1 Detailed list of key startups/SMEs 175
12.8.5.2 Competitive benchmarking of startups/SMEs 176
12.9 COMPETITIVE SCENARIO 177
12.9.1 PRODUCT LAUNCHES 177
12.9.2 DEALS 178
12.9.3 OTHER DEVELOPMENTS 180
13 COMPANY PROFILES 185
13.1 KEY PLAYERS 185
13.1.1 SAINT-GOBAIN 185
13.1.1.1 Business overview 185
13.1.1.2 Products/Solutions/Services offered 186
13.1.1.3 Recent developments 188
13.1.1.3.1 Deals 188
13.1.1.4 MnM view 189
13.1.1.4.1 Right to win 189
13.1.1.4.2 Strategic choices 189
13.1.1.4.3 Weaknesses and competitive threats 189

13.1.2 FREUDENBERG MEDICAL 190
13.1.2.1 Business overview 190
13.1.2.2 Products/Solutions/Services offered 191
13.1.2.3 Recent developments 194
13.1.2.3.1 Product launches 194
13.1.2.3.2 Deals 195
13.1.2.3.3 Expansions 195
13.1.2.4 MnM view 197
13.1.2.4.1 Right to win 197
13.1.2.4.2 Strategic choices 197
13.1.2.4.3 Weaknesses and competitive threats 197
13.1.3 THE LUBRIZOL CORPORATION 198
13.1.3.1 Business overview 198
13.1.3.2 Products/Solutions/Services offered 199
13.1.3.3 Recent developments 200
13.1.3.3.1 Deals 200
13.1.3.3.2 Expansions 200
13.1.3.4 MnM view 201
13.1.3.4.1 Right to win 201
13.1.3.4.2 Strategic choices 201
13.1.3.4.3 Weaknesses and competitive threats 201
13.1.4 W. L. GORE & ASSOCIATES, INC. 202
13.1.4.1 Business overview 202
13.1.4.2 Products/Solutions/Services offered 202
13.1.4.3 MnM view 203
13.1.4.3.1 Right to win 203
13.1.4.3.2 Strategic choices 203
13.1.4.3.3 Weaknesses and competitive threats 203
13.1.5 NORDSON CORPORATION 204
13.1.5.1 Business overview 204
13.1.5.2 Products/Solutions/Services offered 205
13.1.5.3 Recent developments 207
13.1.5.3.1 Product launches 207
13.1.5.3.2 Deals 207
13.1.5.4 MnM view 208
13.1.5.4.1 Right to win 208
13.1.5.4.2 Strategic choices 208
13.1.5.4.3 Weaknesses and competitive threats 208

13.1.6 TE CONNECTIVITY 209
13.1.6.1 Business overview 209
13.1.6.2 Products/Solutions/Services offered 210
13.1.6.3 Recent developments 211
13.1.6.3.1 Product launches 211
13.1.6.4 MnM view 211
13.1.7 ELKEM ASA 212
13.1.7.1 Business overview 212
13.1.7.2 Products/Solutions/Services offered 213
13.1.7.3 Recent developments 214
13.1.7.3.1 Deals 214
13.1.7.3.2 Expansions 214
13.1.7.4 MnM view 214
13.1.8 TRELLEBORG AB 215
13.1.8.1 Business overview 215
13.1.8.2 Products/Solutions/Services offered 216
13.1.8.3 Recent developments 218
13.1.8.3.1 Deals 218
13.1.8.3.2 Other developments 218
13.1.8.4 MnM view 219
13.1.9 RAUMEDIC AG 220
13.1.9.1 Business overview 220
13.1.9.2 Products/Solutions/Services offered 220
13.1.9.3 Recent developments 222
13.1.9.3.1 Product launches 222
13.1.9.3.2 Deals 222
13.1.9.3.3 Expansions 223
13.1.9.4 MnM view 223
13.1.10 SPECTRUM PLASTICS GROUP 224
13.1.10.1 Business overview 224
13.1.10.2 Products/Solutions/Services offered 224
13.1.10.3 Recent developments 226
13.1.10.3.1 Deals 226
13.1.10.3.2 Expansions 226
13.1.10.4 MnM view 227
13.1.11 ZEUS COMPANY LLC 228
13.1.11.1 Business overview 228
13.1.11.2 Products/Solutions/Services offered 228
13.1.11.3 Recent developments 230
13.1.11.3.1 Product launches 230
13.1.11.3.2 Expansions 230
13.1.11.4 MnM view 230
13.2 OTHER PLAYERS 231
13.2.1 ATAG SPA 231
13.2.2 DAVIS STANDARD 232
13.2.3 FBK MEDICAL TUBING 233
13.2.4 PROTERIAL CABLE AMERICA, INC. 234
13.2.5 ICO RALLY 235
13.2.6 ICU MEDICAL, INC. 236
13.2.7 KRATON CORPORATION 237
13.2.8 MICROLUMEN INC. 238
13.2.9 MDC INDUSTRIES 239
13.2.10 NEWAGE INDUSTRIES 240
13.2.11 OPTINOVA 241
13.2.12 PARKER HANNIFIN CORP. 242
13.2.13 TEEL PLASTICS 243
13.2.14 VESTA INC. 244
13.2.15 SMOOTH-BOR PLASTICS 245
14 RESEARCH METHODOLOGY 246
14.1 RESEARCH DATA 246
14.1.1 SECONDARY DATA 247
14.1.1.1 List of key secondary sources 247
14.1.1.2 Key data from secondary sources 247
14.1.2 PRIMARY DATA 248
14.1.2.1 Key data from primary sources 248
14.1.2.2 List of primary interview participants—demand and supply side 248
14.1.2.3 Key industry insights 249
14.1.2.4 Breakdown of interviews with experts 249
14.2 MARKET SIZE ESTIMATION 249
14.2.1 BOTTOM-UP APPROACH 250
14.2.2 TOP-DOWN APPROACH 250
14.3 DATA TRIANGULATION 251
14.4 ASSUMPTIONS 252
14.5 LIMITATIONS AND RISKS 253
15 APPENDIX 254
15.1 DISCUSSION GUIDE 254
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 257
15.3 CUSTOMIZATION OPTIONS 259
15.4 RELATED REPORTS 259
15.5 AUTHOR DETAILS 260

LIST OF TABLES

TABLE 1 LIST OF STANDARDS AND REGULATIONS FOR MEDICAL TUBING 40
TABLE 2 MEDICAL TUBING MARKET: PORTER’S FIVE FORCES ANALYSIS 48
TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 55
TABLE 4 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 55
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 56
TABLE 6 ROLE OF COMPANIES IN MEDICAL TUBING ECOSYSTEM 59
TABLE 7 MEDICAL TUBING MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026–2027 64
TABLE 8 TOP 10 PATENT OWNERS OVER LAST ELEVEN YEARS, 2015–2024 68
TABLE 9 MEDICAL TUBING MARKET: UNMET NEEDS IN KEY END-USE SECTORS 73
TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS (%) 77
TABLE 11 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 77
TABLE 12 HEALTHCARE EXPENDITURES (USD BILLION) 78
TABLE 13 US TARIFF RATES 79
TABLE 14 MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (KILOTON) 83
TABLE 15 MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (KILOTON) 84
TABLE 16 MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 84
TABLE 17 MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 84
TABLE 18 MEDICAL TUBING MARKET, BY MATERIAL, 2022–2025 (KILOTON) 92
TABLE 19 MEDICAL TUBING MARKET, BY MATERIAL, 2026–2031 (KILOTON) 92
TABLE 20 MEDICAL TUBING MARKET, BY MATERIAL, 2022–2025 (USD MILLION) 93
TABLE 21 MEDICAL TUBING MARKET, BY MATERIAL, 2026–2031 (USD MILLION) 93
TABLE 22 MEDICAL TUBING MARKET, BY STRUCTURE, 2022–2025 (KILOTON) 100
TABLE 23 MEDICAL TUBING MARKET, BY STRUCTURE, 2026–2031 (KILOTON) 100
TABLE 24 MEDICAL TUBING MARKET, BY STRUCTURE, 2022–2025 (USD MILLION) 101
TABLE 25 MEDICAL TUBING MARKET, BY STRUCTURE, 2026–2031 (USD MILLION) 101
TABLE 26 MEDICAL TUBING MARKET, BY REGION, 2022–2025 (KILOTON) 106
TABLE 27 MEDICAL TUBING MARKET, BY REGION, 2026–2031 (KILOTON) 107
TABLE 28 MEDICAL TUBING MARKET, BY REGION, 2022–2025 (USD MILLION) 107
TABLE 29 MEDICAL TUBING MARKET, BY REGION, 2026–2031 (USD MILLION) 107
TABLE 30 NORTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY,
2022–2025 (KILOTON) 108
TABLE 31 NORTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY,
2026–2031 (KILOTON) 109
TABLE 32 NORTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 109
TABLE 33 NORTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY,
2026–2031 (USD MILLION) 109
TABLE 34 NORTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (KILOTON) 109
TABLE 35 NORTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (KILOTON) 110
TABLE 36 NORTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 110
TABLE 37 NORTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 110
TABLE 38 US: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (KILOTON) 111
TABLE 39 US: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (KILOTON) 111
TABLE 40 US: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 112
TABLE 41 US: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 112
TABLE 42 CANADA: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (KILOTON) 113
TABLE 43 CANADA: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (KILOTON) 113
TABLE 44 CANADA: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 113
TABLE 45 CANADA: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 114
TABLE 46 MEXICO: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (KILOTON) 114
TABLE 47 MEXICO: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (KILOTON) 115
TABLE 48 MEXICO: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 115
TABLE 49 MEXICO: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 115
TABLE 50 EUROPE: MEDICAL TUBING MARKET, BY COUNTRY, 2022–2025 (KILOTON) 116
TABLE 51 EUROPE: MEDICAL TUBING MARKET, BY COUNTRY, 2026–2031 (KILOTON) 116
TABLE 52 EUROPE: MEDICAL TUBING MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 116
TABLE 53 EUROPE: MEDICAL TUBING MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 117
TABLE 54 EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (KILOTON) 117
TABLE 55 EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (KILOTON) 117
TABLE 56 EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 118
TABLE 57 EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 118
TABLE 58 GERMANY: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (KILOTON) 119
TABLE 59 GERMANY: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (KILOTON) 119
TABLE 60 GERMANY: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 119
TABLE 61 GERMANY: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 119
TABLE 62 FRANCE: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (KILOTON) 120
TABLE 63 FRANCE: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (KILOTON) 120
TABLE 64 FRANCE: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 121
TABLE 65 FRANCE: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 121
TABLE 66 UK: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (KILOTON) 122
TABLE 67 UK: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (KILOTON) 122
TABLE 68 UK: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 122
TABLE 69 UK: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 123
TABLE 70 SPAIN: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (KILOTON) 123
TABLE 71 SPAIN: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (KILOTON) 124
TABLE 72 SPAIN: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 124
TABLE 73 SPAIN: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 124
TABLE 74 ITALY: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (KILOTON) 125
TABLE 75 ITALY: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (KILOTON) 125
TABLE 76 ITALY: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 125
TABLE 77 ITALY: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 126
TABLE 78 NETHERLANDS: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (KILOTON) 126
TABLE 79 NETHERLANDS: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (KILOTON) 127
TABLE 80 NETHERLANDS: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 127
TABLE 81 NETHERLANDS: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 127
TABLE 82 REST OF EUROPE: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (KILOTON) 128
TABLE 83 REST OF EUROPE: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (KILOTON) 128
TABLE 84 REST OF EUROPE: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 128
TABLE 85 REST OF EUROPE: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 128
TABLE 86 ASIA PACIFIC: MEDICAL TUBING MARKET, BY COUNTRY, 2022–2025 (KILOTON) 130
TABLE 87 ASIA PACIFIC: MEDICAL TUBING MARKET, BY COUNTRY, 2026–2031 (KILOTON) 130
TABLE 88 ASIA PACIFIC: MEDICAL TUBING MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 130
TABLE 89 ASIA PACIFIC: MEDICAL TUBING MARKET, BY COUNTRY,
2026–2031 (USD MILLION) 131
TABLE 90 ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (KILOTON) 131
TABLE 91 ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (KILOTON) 131
TABLE 92 ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 131
TABLE 93 ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 132
TABLE 94 CHINA: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (KILOTON) 133
TABLE 95 CHINA: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (KILOTON) 133
TABLE 96 CHINA: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 133
TABLE 97 CHINA: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 133
TABLE 98 JAPAN: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (KILOTON) 134
TABLE 99 JAPAN: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (KILOTON) 134
TABLE 100 JAPAN: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 135
TABLE 101 JAPAN: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 135
TABLE 102 INDIA: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (KILOTON) 136
TABLE 103 INDIA: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (KILOTON) 136
TABLE 104 INDIA: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 136
TABLE 105 INDIA: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 137
TABLE 106 SOUTH KOREA: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (KILOTON) 137
TABLE 107 SOUTH KOREA: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (KILOTON) 138
TABLE 108 SOUTH KOREA: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 138
TABLE 109 SOUTH KOREA: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 138
TABLE 110 REST OF ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (KILOTON) 139
TABLE 111 REST OF ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (KILOTON) 139
TABLE 112 REST OF ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 139
TABLE 113 REST OF ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 140
TABLE 114 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY COUNTRY,
2022–2025 (KILOTON) 140
TABLE 115 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY COUNTRY,
2026–2031 (KILOTON) 141
TABLE 116 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 141
TABLE 117 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY COUNTRY,
2026–2031 (USD MILLION) 141
TABLE 118 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (KILOTON) 142
TABLE 119 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (KILOTON) 142
TABLE 120 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 142
TABLE 121 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 142
TABLE 122 SAUDI ARABIA: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (KILOTON) 144
TABLE 123 SAUDI ARABIA: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (KILOTON) 144
TABLE 124 SAUDI ARABIA: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 144
TABLE 125 SAUDI ARABIA: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 144
TABLE 126 UAE: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (KILOTON) 145
TABLE 127 UAE: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (KILOTON) 145
TABLE 128 UAE: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 146
TABLE 129 UAE: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 146
TABLE 130 REST OF GCC: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (KILOTON) 146
TABLE 131 REST OF GCC: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (KILOTON) 147
TABLE 132 REST OF GCC: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 147
TABLE 133 REST OF GCC: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 147
TABLE 134 SOUTH AFRICA: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (KILOTON) 148
TABLE 135 SOUTH AFRICA: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (KILOTON) 148
TABLE 136 SOUTH AFRICA: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 148
TABLE 137 SOUTH AFRICA: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 148
TABLE 138 EGYPT: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (KILOTON) 149
TABLE 139 EGYPT: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (KILOTON) 149
TABLE 140 EGYPT: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 149
TABLE 141 EGYPT: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 150
TABLE 142 REST OF MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (KILOTON) 150
TABLE 143 REST OF MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (KILOTON) 150
TABLE 144 REST OF MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 151
TABLE 145 REST OF MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 151
TABLE 146 SOUTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY,
2022–2025 (KILOTON) 151
TABLE 147 SOUTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY,
2026–2031 (KILOTON) 152
TABLE 148 SOUTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 152
TABLE 149 SOUTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY,
2026–2031 (USD MILLION) 152
TABLE 150 SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (KILOTON) 152
TABLE 151 SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (KILOTON) 153
TABLE 152 SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 153
TABLE 153 SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 153
TABLE 154 BRAZIL: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (KILOTON) 154
TABLE 155 BRAZIL: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (KILOTON) 154
TABLE 156 BRAZIL: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 154
TABLE 157 BRAZIL: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 154
TABLE 158 ARGENTINA: MEDICAL TUBING MARKET, BY APPLICATION, 2022–2025 (KILOTON) 155
TABLE 159 ARGENTINA: MEDICAL TUBING MARKET, BY APPLICATION, 2026–2031 (KILOTON) 155
TABLE 160 ARGENTINA: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 155
TABLE 161 ARGENTINA: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 156
TABLE 162 REST OF SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (KILOTON) 156
TABLE 163 REST OF SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (KILOTON) 156
TABLE 164 REST OF SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 157
TABLE 165 REST OF SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 157
TABLE 166 MEDICAL TUBING MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2020–2026 159
TABLE 167 MEDICAL TUBING MARKET: DEGREE OF COMPETITION, 2025 162
TABLE 168 MEDICAL TUBING MARKET: REGION FOOTPRINT 170
TABLE 169 MEDICAL TUBING MARKET: STRUCTURE FOOTPRINT 171
TABLE 170 MEDICAL TUBING MARKET: MATERIAL FOOTPRINT 172
TABLE 171 MEDICAL TUBING MARKET: APPLICATION FOOTPRINT 173
TABLE 172 MEDICAL TUBING MARKET: KEY STARTUPS/SMES 175
TABLE 173 MEDICAL TUBING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 176
TABLE 174 MEDICAL TUBING MARKET: PRODUCT LAUNCHES, JANUARY 2020–JULY 2026 177
TABLE 175 MEDICAL TUBING MARKET: DEALS, JANUARY 2020–JULY 2026 178
TABLE 176 MEDICAL TUBING MARKET: OTHER DEVELOPMENTS, JANUARY 2020–JULY 2026 180
TABLE 177 SAINT-GOBAIN: COMPANY OVERVIEW 185
TABLE 178 SAINT-GOBAIN: PRODUCTS/SOLUTIONS/SERVICES OFFERED 186
TABLE 179 SAINT-GOBAIN: DEALS, JANUARY 2020–JULY 2026 188
TABLE 180 FREUDENBERG MEDICAL: COMPANY OVERVIEW 190
TABLE 181 FREUDENBERG MEDICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED 191
TABLE 182 FREUDENBERG MEDICAL: PRODUCT LAUNCHES, JANUARY 2020–JULY 2026 194
TABLE 183 FREUDENBERG MEDICAL: DEALS, JANUARY 2020–JULY 2026 195
TABLE 184 FREUDENBERG MEDICAL: EXPANSIONS, JANUARY 2020–JULY 2026 195
TABLE 185 THE LUBRIZOL CORPORATION: COMPANY OVERVIEW 198
TABLE 186 THE LUBRIZOL CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 199
TABLE 187 THE LUBRIZOL CORPORATION: DEALS, JANUARY 2020–JULY 2026 200
TABLE 188 THE LUBRIZOL CORPORATION: EXPANSIONS, JANUARY 2020–JULY 2026 200
TABLE 189 W. L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW 202
TABLE 190 W. L. GORE & ASSOCIATES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 202
TABLE 191 NORDSON CORPORATION: COMPANY OVERVIEW 204
TABLE 192 NORDSON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 205
TABLE 193 NORDSON CORPORATION: PRODUCT LAUNCHES, JANUARY 2020–JULY 2026 207
TABLE 194 NORDSON CORPORATION: DEALS, JANUARY 2020–JULY 2026 207
TABLE 195 TE CONNECTIVITY: COMPANY OVERVIEW 209
TABLE 196 TE CONNECTIVITY: PRODUCTS/SOLUTIONS/SERVICES OFFERED 210
TABLE 197 TE CONNECTIVITY: PRODUCT LAUNCHES, JANUARY 2020–JULY 2026 211
TABLE 198 ELKEM ASA: COMPANY OVERVIEW 212
TABLE 199 ELKEM ASA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 213
TABLE 200 ELKEM ASA: DEALS, JANUARY 2020–JULY 2026 214
TABLE 201 ELKEM ASA: EXPANSIONS, JANUARY 2020–JULY 2026 214
TABLE 202 TRELLEBORG AB: COMPANY OVERVIEW 215
TABLE 203 TRELLEBORG AB: PRODUCTS/SOLUTIONS/SERVICES OFFERED 216
TABLE 204 TRELLEBORG AB: DEALS, JANUARY 2020–JULY 2026 218
TABLE 205 TRELLEBORG AB: OTHER DEVELOPMENTS, JANUARY 2020–JULY 2026 218
TABLE 206 RAUMEDIC AG: COMPANY OVERVIEW 220
TABLE 207 RAUMEDIC AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 220
TABLE 208 RAUMEDIC AG: PRODUCT LAUNCHES, JANUARY 2020–JULY 2026 222
TABLE 209 RAUMEDIC AG: DEALS, JANUARY 2020–JULY 2026 222
TABLE 210 RAUMEDIC AG: EXPANSIONS, JANUARY 2020–JULY 2026 223
TABLE 211 SPECTRUM PLASTICS GROUP: COMPANY OVERVIEW 224
TABLE 212 SPECTRUM PLASTICS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 224
TABLE 213 SPECTRUM PLASTICS GROUP: DEALS, JANUARY 2020–JULY 2026 226
TABLE 214 SPECTRUM PLASTICS GROUP: EXPANSIONS, JANUARY 2020–JULY 2026 226
TABLE 215 ZEUS COMPANY LLC: COMPANY OVERVIEW 228
TABLE 216 ZEUS COMPANY LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 228
TABLE 217 ZEUS COMPANY LLC: PRODUCT LAUNCHES, JANUARY 2020–JULY 2026 230
TABLE 218 ZEUS COMPANY LLC: EXPANSIONS, JANUARY 2020–JULY 2026 230
TABLE 219 ATAG SPA: COMPANY OVERVIEW 231
TABLE 220 DAVIS STANDARD: COMPANY OVERVIEW 232
TABLE 221 FBK MEDICAL TUBING: COMPANY OVERVIEW 233
TABLE 222 PROTERIAL CABLE AMERICA, INC.: COMPANY OVERVIEW 234
TABLE 223 ICO RALLY: COMPANY OVERVIEW 235
TABLE 224 ICU MEDICAL, INC.: COMPANY OVERVIEW 236
TABLE 225 KRATON CORPORATION: COMPANY OVERVIEW 237
TABLE 226 MICROLUMEN INC.: COMPANY OVERVIEW 238
TABLE 227 MDC INDUSTRIES: COMPANY OVERVIEW 239
TABLE 228 NEWAGE INDUSTRIES: COMPANY OVERVIEW 240
TABLE 229 OPTINOVA: COMPANY OVERVIEW 241
TABLE 230 PARKER HANNIFIN CORP.: COMPANY OVERVIEW 242
TABLE 231 TEEL PLASTICS: COMPANY OVERVIEW 243
TABLE 232 VESTA INC.: COMPANY OVERVIEW 244
TABLE 233 SMOOTH-BOR PLASTICS: COMPANY OVERVIEW 245
TABLE 234 LIST OF KEY SECONDARY SOURCES 247

LIST OF FIGURES

FIGURE 1 MEDICAL TUBING MARKET SEGMENTATION AND REGIONAL SCOPE 26
FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS 29
FIGURE 3 GLOBAL MEDICAL TUBING MARKET, 2022–2031 (USD MILLION) 29
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL TUBING MARKET, 2020–2026 30
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF MEDICAL TUBING MARKET 31
FIGURE 6 HIGH-GROWTH SEGMENTS IN MEDICAL TUBING MARKET, 2026–2031 32
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 33
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN MEDICAL TUBING MARKET DURING FORECAST PERIOD 34
FIGURE 9 SPECIALTY POLYMERS SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 34
FIGURE 10 BRAIDED-TUBING SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 35
FIGURE 11 BULK DISPOSABLE TUBING SEGMENT TO LEAD OVERALL MARKET BY 2031 35
FIGURE 12 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 36
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL TUBING MARKET 37
FIGURE 14 MEDICAL TUBING MARKET: PORTER’S FIVE FORCES ANALYSIS 48
FIGURE 15 MEDICAL TUBING MARKETING MARKET: VALUE CHAIN ANALYSIS 51
FIGURE 16 IMPORT DATA FOR HS CODE 3917-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2021–2025 (USD MILLION) 57
FIGURE 17 EXPORT DATA RELATED TO HS CODE 3917-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2021–2025 (USD MILLION) 58
FIGURE 18 MEDICAL TUBING MARKET: KEY PARTICIPANT IN ECOSYSTEM 58
FIGURE 19 MEDICAL TUBING MARKET: ECOSYSTEM ANALYSIS 59
FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS IN MEDICAL TUBING MARKET 60
FIGURE 21 MEDICAL TUBING MARKET: GRANTED PATENTS, 2016–2025 66
FIGURE 22 NUMBER OF PATENTS PER YEAR, 2016–2025 66
FIGURE 23 LEGAL STATUS OF PATENTS, 2016–2025 67
FIGURE 24 TOP JURISDICTION, BY DOCUMENT, 2016–2025 67
FIGURE 25 TOP 10 PATENT APPLICANTS, 2016–2025 68
FIGURE 26 FUTURE APPLICATIONS 69
FIGURE 27 AVERAGE SELLING PRICE, BY REGION, 2022–2025 (USD/KG) 70
FIGURE 28 AVERAGE SELLING PRICE FOR TOP THREE APPLICATIONS, BY KEY PLAYER,
2025 (USD/KG) 71
FIGURE 29 AVERAGE SELLING PRICE TREND, BY MATERIAL, 2022–2025 (USD/KG) 71
FIGURE 30 MEDICAL TUBING, INVESTMENT AND FUNDING SCENARIO, 2020–2024 72
FIGURE 31 MEDICAL TUBING MARKET: DECISION-MAKING FACTORS 76
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 76
FIGURE 33 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 77
FIGURE 34 CATHETERS & CANNULAS TO BE LARGEST APPLICATION OF MEDICAL TUBING MARKET DURING FORECAST PERIOD 83
FIGURE 35 RUBBERS SEGMENT TO LEAD MEDICAL TUBING MARKET DURING FORECAST PERIOD 92
FIGURE 36 MULTI-LUMEN SEGMENT TO DOMINATE MEDICAL TUBING MARKET DURING FORECAST PERIOD 100
FIGURE 37 INDIA TO BE FASTEST-GROWING MARKET FOR MEDICAL TUBING DURING FORECAST PERIOD 106
FIGURE 38 NORTH AMERICA: MEDICAL TUBING MARKET SNAPSHOT 108
FIGURE 39 ASIA PACIFIC: MEDICAL TUBING MARKET SNAPSHOT 129
FIGURE 40 MEDICAL TUBING MARKET: REVENUE ANALYSIS OF KEY COMPANIES, 2023–2025 161
FIGURE 41 MEDICAL TUBING MARKET SHARE ANALYSIS, 2025 162
FIGURE 42 MEDICAL TUBING MARKET: COMPANY VALUATION OF LEADING COMPANIES, 2025 165
FIGURE 43 MEDICAL TUBING MARKET: FINANCIAL METRICS OF LEADING COMPANIES, 2025 165
FIGURE 44 BRAND COMPARISON 166
FIGURE 45 COMPANY EVALUATION MATRIX, KEY PLAYERS, 2025 168
FIGURE 46 MEDICAL TUBING MARKET: COMPANY FOOTPRINT 169
FIGURE 47 MEDICAL TUBING MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2025 175
FIGURE 48 SAINT-GOBAIN: COMPANY SNAPSHOT 186
FIGURE 49 FREUDENBERG GROUP: COMPANY SNAPSHOT 191
FIGURE 50 NORDSON CORPORATION: COMPANY SNAPSHOT 205
FIGURE 51 TE CONNECTIVITY: COMPANY SNAPSHOT 210
FIGURE 52 ELKEM ASA: COMPANY SNAPSHOT 213
FIGURE 53 TRELLEBORG AB: COMPANY SNAPSHOT 216
FIGURE 54 MEDICAL TUBING MARKET: RESEARCH DESIGN 246
FIGURE 55 MEDICAL TUBING MARKET: BOTTOM-UP APPROACH 250
FIGURE 56 MEDICAL TUBING MARKET: TOP-DOWN APPROACH 250
FIGURE 57 MARKET SIZE ESTIMATION: MEDICAL TUBING MARKET, TOP-DOWN APPROACH 251
FIGURE 58 MEDICAL TUBING MARKET: DATA TRIANGULATION 252

---

---